Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review

Yazar: Salloum, Naji C., Fava, Maurizio, Ball, Sophia, Papakostas, George I.
Yayımlandı Mol Psychiatry (2020)

Towards the clinical implementation of pharmacogenetics in bipolar disorder

Yazar: Salloum, Naji C, McCarthy, Michael J, Leckband, Susan G, Kelsoe, John R
Baskı/Yayın Bilgisi 2014

A Reciprocal Effects Analysis of Cannabis Use and Perceptions of Risk

Yazar: Salloum, Naji C., Krauss, Melissa J., Agrawal, Arpana, Bierut, Laura J., Grucza, Richard A.
Yayımlandı Addiction (2018)

Time to Relapse after a Single Administration of Intravenous Ketamine Augmentation in Unipolar Treatment-Resistant Depression

Yazar: Salloum, Naji C., Fava, Maurizio, Hock, Rebecca S., Freeman, Marlene P., Flynn, Martina, Hoeppner, Bettina, Cusin, Cristina, Iosifescu, Dan V., Trivedi, Madhukar H., Sanacora, Gerard, Mathew, Sanjay J., Debattista, Charles, Ionescu, Dawn F., Papakostas, George I.
Yayımlandı J Affect Disord (2019)

From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation

Yazar: Salloum, Naji C, Buchalter, Erica LF, Chanani, Swati, Espejo, Gemma, Ismail, Mahjabeen S, Laine, Randy O, Nageeb, Maysaa, Srivastava, A Benjamin, Trapp, Nicholas, Trillo, Ludwig, Vance, Erica, Wenzinger, Michael, Hartz, Sarah M, David, Sean P, Chen, Li-Shiun
Yayımlandı Pharmacogenomics (2018)